Healthcare provider profile · identity verified

Bradley A Allen, MD

Family Practice · BEAVER DAM, WI · NPI 1447201918

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	805	227
Amlodipine Besylate	Amlodipine Besylate	458	111
Lisinopril	Lisinopril	425	123
Simvastatin	Simvastatin	380	101
Omeprazole	Omeprazole	379	106
Levothyroxine Sodium	Levothyroxine Sodium	309	75
Metoprolol Succinate	Metoprolol Succinate	267	66
Metoprolol Tartrate	Metoprolol Tartrate	258	74
Losartan Potassium	Losartan Potassium	232	63
Furosemide	Furosemide	226	70
Metformin Hcl	Metformin Hcl	202	56
Hydrochlorothiazide	Hydrochlorothiazide	169	53
Eliquis	Apixaban	142	35
Metformin Hcl Er	Metformin Hcl	134	39
Rosuvastatin Calcium	Rosuvastatin Calcium	134	37
Gabapentin	Gabapentin	125	31
Tamsulosin Hcl	Tamsulosin Hcl	124	41
Famotidine	Famotidine	118	27
Allopurinol	Allopurinol	108	32
Fluticasone Propionate	Fluticasone Propionate	104	42
Albuterol Sulfate Hfa	Albuterol Sulfate	102	43
Finasteride	Finasteride	95	29
Potassium Chloride	Potassium Chloride	87	30
Clopidogrel	Clopidogrel Bisulfate	84	21
Lorazepam	Lorazepam	83	23
Sertraline Hcl	Sertraline Hcl	81	21
Pantoprazole Sodium	Pantoprazole Sodium	78	28
Warfarin Sodium	Warfarin Sodium	76	17
Clonazepam	Clonazepam	73	11
Duloxetine Hcl	Duloxetine Hcl	71	22
Montelukast Sodium	Montelukast Sodium	71	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	68	23
Carvedilol	Carvedilol	63	19
Pravastatin Sodium	Pravastatin Sodium	56	15
Alendronate Sodium	Alendronate Sodium	55	21
Benazepril Hcl	Benazepril Hcl	53	11
Donepezil Hcl	Donepezil Hcl	52	13
Jardiance	Empagliflozin	52	16
Quetiapine Fumarate	Quetiapine Fumarate	50	suppressed
Trazodone Hcl	Trazodone Hcl	50	15
Atenolol	Atenolol	49	14
Xarelto	Rivaroxaban	49	12
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Ozempic	Semaglutide	47	13
Triamcinolone Acetonide	Triamcinolone Acetonide	46	16
Zolpidem Tartrate	Zolpidem Tartrate	46	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	13
Citalopram Hbr	Citalopram Hydrobromide	42	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	13
Spironolactone	Spironolactone	40	11
Mirtazapine	Mirtazapine	39	suppressed
Tramadol Hcl	Tramadol Hcl	39	13
Ventolin Hfa	Albuterol Sulfate	39	11
Dicyclomine Hcl	Dicyclomine Hcl	36	11
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Bupropion Hcl Sr	Bupropion Hcl	35	suppressed
Glipizide Er	Glipizide	35	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Glimepiride	Glimepiride	34	11
Ketoconazole	Ketoconazole	34	11
Enalapril Maleate	Enalapril Maleate	33	suppressed
Nitroglycerin	Nitroglycerin	33	20
Lovastatin	Lovastatin	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Amoxicillin	Amoxicillin	28	17
Buspirone Hcl	Buspirone Hcl	28	suppressed
Digoxin	Digoxin	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Diazepam	Diazepam	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Glipizide	Glipizide	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Olanzapine	Olanzapine	26	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Naproxen	Naproxen	24	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	20	suppressed
Pregabalin	Pregabalin	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Azithromycin	Azithromycin	18	17
Celecoxib	Celecoxib	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Victoza 2-Pak	Liraglutide	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Cephalexin	Cephalexin	16	15
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Prednisone	Prednisone	16	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Valacyclovir	Valacyclovir Hcl	16	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Estradiol	Estradiol	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Pulmicort Flexhaler	Budesonide	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Valsartan	Valsartan	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Baclofen	Baclofen	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Dulera	Mometasone/Formoterol	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error